Clinical disposition, metabolism and in vitro drug–drug interaction properties of omadacycline

Jimmy FlarakosDrug Metabolism and Pharmacokinetics and

Yancy DuDrug Metabolism and Pharmacokinetics and

Helen GuDrug Metabolism and Pharmacokinetics and

Lai WangDrug Metabolism and Pharmacokinetics and

Heidi J. EinolfDrug Metabolism and Pharmacokinetics and

Dung Y. ChunDrug Metabolism and Pharmacokinetics and

Bing ZhuDrug Metabolism and Pharmacokinetics and

Natalia AlexanderDrug Metabolism and Pharmacokinetics and

Adrienne NatrilloDrug Metabolism and Pharmacokinetics and

Imad HannaDrug Metabolism and Pharmacokinetics and

Lillian TingClinical Pharmacology, Gilead Sciences, Foster City, CA, USA

Wei ZhouDrug Metabolism and Pharmacokinetics and

Kiran DoleTranslational Medicine, Novartis Institutes for Biomedical Research, DMPK, East Hanover, NJ, USA,

Haiying SunDrug Metabolism and Pharmacokinetics and

Steven J. KovacsTranslational Medicine, Novartis Institutes for Biomedical Research, DMPK, East Hanover, NJ, USA,

Daniel S. SteinTranslational Medicine, Novartis Institutes for Biomedical Research, DMPK, East Hanover, NJ, USA,

S. Ken TanakaParatek Pharmaceuticals, Clinical and Medical Affairs, King of Prussia, PA, USA, and

Stephen VillanoParatek Pharmaceuticals, Clinical and Medical Affairs, King of Prussia, PA, USA, and Correspondence[email protected]

James B. MangoldDrug Metabolism and Pharmacokinetics and

Your download is now in progress and you may close this window